CORRECTION
By Adnews Staff
Yesterday Adnews described Activase, a drug produced by Hoffmann-La Roche Canada which acts on blood clots, as awaiting regulatory clearance. This is not the case. Activase has been cleared and is on the market. Adnews regrets the error.
« Back Next »
Comments
blog comments powered by Disqus